EGFR FISH analysis in colorectal cancer as a tool in selecting patients for antiEGFR monoclonal antibodies therapy
The recent introduction of targeted therapies in the treatment of patients with metastatic colorectal cancer (mCRC) not only improved efficacy but also toxicity and costs of the therapy, therefore requiring the identification of decision-making tools to select patients who are likely to benefit from...
Saved in:
Main Authors: | Mauro Moroni (Author), Giovanna Marrapese (Author), Silvio Veronese (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy
by: Fernando Concha-Benavente, et al.
Published: (2017) -
Strong nuclear EGFR expression in colorectal carcinomas is associated with cyclin-D1 but not with gene EGFR amplification
by: Dekanić Andrea, et al.
Published: (2011) -
Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road
by: Alejandro Ríos-Hoyo, et al.
Published: (2024) -
Discovery of potent allosteric antibodies inhibiting EGFR
by: Léxane Fournier, et al.
Published: (2024) -
Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
by: Brian J. Thomas, et al.
Published: (2023)